Senior Director, Regulatory Affairs
Allucent
Dr. Taylor is an accomplished regulatory affairs subject matter expert, responsible for regulatory and clinical strategy support for drugs, biologics, medical devices, and combination products. With 14 years of research and industry experience as a biomedical engineer and regulatory affairs professional, his experience spans preclinical, clinical, and post marketing stages of development, including extensive experience in regulatory pathways in the US, including pre-RFD/RFD, IND, IDE, marketing applications and all expedited program options. Dr. Taylor has a broad knowledge of FDA meeting preparation and strategy, having led or participated in more than 30 formal FDA meetings across all product types, plus many more informal interactions and is well versed in FDA guidance and US regulations under 21 CFR pertaining to product development.
In his role as Senior Director, Regulatory Affairs at Allucent, Dr. Taylor shares oversight of the Clinical Strategy group, focusing on clinical development strategies and protocol design/optimization for drugs, biologics, medical devices, and combination products. He holds a Ph.D. in Biomedical Engineering from Pennsylvania State University.
Sponsored Presentation: Proactivity and best practices in the evolving FDA landscape
Wednesday, October 8, 2025
10:45 AM - 11:10 AM EST